Back to search
FDAFDA · Food and drugs·Recall number D-1347-2016

FUCONPO CAPSULE, packaged in a 30-count bottle within a box, remaining labeling contains Chinese characters.

Published July 20, 2016 · Recall initiated: April 20, 2016

Summary

FDA records drug Class II recall D-1347-2016, published July 20, 2016 and initiated April 20, 2016. Recalling firm: Murray International Trading Co., Inc.; Status: Terminated; Reported quantity: unknown; Lot: All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Murray International Trading Co., Inc.
Distributor
Nationwide and Puerto Rico
Lot
All lots
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was FUCONPO CAPSULE, packaged in a 30-count bottle within a box, remaining labeling contains Chinese characters. recalled?

Yes. FDA published recall D-1347-2016 on July 20, 2016. Reported hazard: Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone